泡泡瑪特再創歷史新高,市值逼近3400億港元,85後創始人王寧成河南新首富
泡泡瑪特(9992.HK)盤中拉昇升超3%,報253港元,再創歷史新高。該股繼2024年累升346%後,2025年至今再度累升181%,目前市值逼近3400億港元。福布斯富豪榜實時數據顯示,王寧目前身家為207億美元,牧原股份創始人秦英林身家為169億美元。王寧已取代秦英林,成為河南新首富。據悉,泡泡瑪特創始人、執行董事長兼CEO王寧,1987年出生於河南新鄉,2009年畢業於鄭州西亞斯學院廣吿專業,2010年創立泡泡瑪特。他掀起了盲盒熱潮,推出多款精美設計的玩偶,其中Labubu是目前旗下最受歡迎的單品。泡泡瑪特2024年年報顯示,王寧持有公司股權佔比為48.73%。

Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.